• Access to genomic surveillance: Open science and public health

  • Oct 16 2024
  • Length: 18 mins
  • Podcast

Access to genomic surveillance: Open science and public health

  • Summary

  • The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development.

    In today’s podcast, web editor Nicole Raleigh speaks with Dr Evan Floden, CEO and co-founder of Seqera, a data orchestration and genomics analysis company, about barriers of entry to genomic surveillance in public health labs and how these can be lowered to support future bioinformaticians, aiding acceleration and quality and accuracy in R&D.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Access to genomic surveillance: Open science and public health

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.